IFNA1 and COVID-19: When we compare the interferon (IFN) response between COVID-19- and Influenza-induced sepsis, we find that IFN is released later during the course of severe COVID-19 (following the pro-inflammatory phase) and is less pronounced, leading to longer disease and higher severity [37].